Iovance Biotherapeutics Inc
NASDAQ:IOVA
Iovance Biotherapeutics, Inc. Stock, NASDAQ:IOVA
999 Skyway Road, Suite 150, San Carlos, California 94070
United States of America
Phone: +1.650.260.7120
Number of Employees: 148
Description
Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.